COMPUGROUP MEDICAL: Encouraging start for 2022 | BUY | EUR66
COMPUGROUP MEDICAL - BUY | EUR66Encouraging start for 2022
Q1 2022 results were above expectations
Lfl revenue growth was driven by the Hospital division
Company guidance for 2022 and medium-term targets are reiterated
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.